CompletedNot applicableNCT03372720
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Studying Vaginal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Principal Investigator
- Allison Quick, MD, M.DOhio State University Comprehensive Cancer Center
- Intervention
- Laser Therapy(procedure)
- Enrollment
- 19 enrolled
- Eligibility
- FEMALE
- Timeline
- 2018 – 2022
Study locations (4)
- Johns Hopkins University, Baltimore, Maryland, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03372720 on ClinicalTrials.govOther trials for Vaginal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07407647Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerOhio State University Comprehensive Cancer Center
- RECRUITINGPHASE2NCT06686043HPV Vaccine, Imiquimod, and Metformin Combination TrialBaylor College of Medicine
- ACTIVE NOT RECRUITINGNCT04713618Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyOhio State University Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGNCT00791635Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerM.D. Anderson Cancer Center